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Introduction
Developing Drosophila melanogaster oocytes use both actin 
and microtubule cytoskeletal systems to construct and maintain 
internal landmarks that defi  ne the dorsal-ventral and anterior-
posterior axes (Theurkauf et al., 1992; Clark et al., 1994; Pokrywka 
and Stephenson, 1995; Polesello et al., 2002). The cappuccino 
and spire genes encode actin fi  lament nucleation factors (Quinlan 
et al., 2005), and mutation of either gene disrupts localization of 
the earliest known polarity determinants (Manseau and Schupbach, 
1989; Manseau et al., 1996). spire and cappuccino were originally 
identifi  ed in the same genetic screen (Manseau and Schupbach, 
1989), and loss of either results in the premature onset of micro-
tubule-dependent fast cytoplasmic streaming during oogenesis, 
loss of oocyte polarity, and female sterility (Theurkauf, 1994; 
Emmons et al., 1995). Rosales-Nieves et al. (2006) demonstrated 
a genetic interaction between spire and cappuccino by showing 
that premature cytoplasmic streaming occurs in fl  ies hetero-
zygous for mutations in both genes. Mutation of Drosophila 
profi  lin (Chickadee) or addition of the actin-depolymerizing toxin 
cytochalasin D (Emmons et al., 1995; Manseau et al., 1996) also 
cause premature fast cytoplasmic streaming. Together, these data 
suggest that actin polymerization driven by Spire (Spir), Cappuccino 
(Capu), and Chickadee suppresses fast cytoplasmic streaming 
until the appropriate point in oogenesis (Serbus et al., 2005).
Consistent with genetic data, Rosales-Nieves et al. (2006) 
recently showed that Spir and Capu proteins interact directly. 
These authors found that the N-terminal region of Spir, which 
contains the kinase noncatalytic C-lobe domain (KIND) and a 
cluster of actin-binding WH2 domains (Wiskott-Aldrich syndrome 
protein homology domain 2), binds to the formin homology 2 
(FH2) domain of Capu. Their data suggest that interaction is 
mediated by direct binding of the WH2 cluster to the FH2 domain. 
These authors report that the Spir–Capu interaction has no effect 
on actin nucleation by either protein but that interaction with 
Spir inhibits FH2-dependent cross-linking of actin fi  laments and 
microtubules. Based on these data, Rosales-Nieves et al. (2006) 
propose a model in which Spir and Capu inhibit premature 
cytoplasmic streaming by cross-linking microtubules to actin 
fi  laments in the oocyte cortex.
Interactions between Spir and Capu have been studied 
only in Drosophila, but there is evidence linking the two pro-
teins in other organisms. In sequenced metazoan genomes, 
Capu family formins appear only in organisms that also contain 
Spir family genes (Higgs and Peterson, 2005). Mammals have two 
copies of each gene. Arthropods, including Drosophila, contain 
at least one spire and one cappuccino gene, whereas nematodes, 
such as Caenorhabditis elegans, contain neither.   Because nema-
todes diverged from arthropods long after Deuterostomes diverged 
from Protostomes, it appears that nematodes lost both genes at 
some point in their evolution. Schumacher et al. (2004) found 
Regulatory interactions between two actin 
nucleators, Spire and Cappuccino
Margot E. Quinlan,
2 Susanne Hilgert,
1 Anaid Bedrossian,
1 R. Dyche Mullins,
2 and Eugen Kerkhoff
1
1Bayerisches Genomforschungsnetzwerk (BayGene), Institut für funktionelle Genomik, Universität Regensburg, 93053 Regensburg, Germany
2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94107
  S
pire and Cappuccino are actin nucleation factors 
that are required to establish the polarity of Droso-
phila melanogaster oocytes. Their mutant pheno-
types are nearly identical, and the proteins interact 
biochemically. We find that the interaction between 
Spire and Cappuccino family proteins is conserved across 
metazoan phyla and is mediated by binding of the formin 
homology 2 (FH2) domain from Cappuccino (or its mam-
malian homologue formin-2) to the kinase noncatalytic 
C-lobe domain (KIND) from Spire. In vitro, the KIND 
domain is a monomeric folded domain. Two KIND mono-
mers bind each FH2 dimer with nanomolar afﬁ  nity and 
strongly inhibit actin nucleation by the FH2 domain. 
In contrast, formation of the Spire–Cappuccino complex 
enhances actin nucleation by Spire. In Drosophila oocytes, 
Spire localizes to the cortex early in oogenesis and dis-
appears around stage 10b, coincident with the onset of 
cytoplasmic streaming.
Correspondence to Dyche Mullins: Dyche@mullinslab.ucsf.edu; or Eugen Kerkhoff: 
Eugen.Kerkhoff@klinik.uni-regensburg.de
Abbreviations used in this paper: DAD, Diaphanous autoinhibitory domain; 
DID, Diaphanous inhibitory domain; FH, formin homology; Fmn2, formin-2; 
KIND, kinase noncatalytic C-lobe domain; mRFP, monomeric RFP; TCEP, 
Tris(2-carboxyethyl) phosphine.
The online version of this article contains supplemental material.JCB • VOLUME 179 • NUMBER 1 • 2007  118
that the patterns of spir-1 and formin-2 (fmn2) expression are 
nearly identical in developing and adult mice.
We also note that Spir and Capu homologues are found in 
a variety of polarized cells, including Drosophila and Xenopus 
laevis oocytes (Eg6 or Xenopus Spir-2; Le Goff et al., 2006), 
mammalian eggs (Fmn2; Leader et al., 2002), neurons (Leader and 
Leder, 2000; Schumacher et al., 2004), and polarized epithelial 
cells (formin-1; Kobielak et al., 2004). In Xenopus oocytes, the 
mRNA of Spir-2 (Eg6) localizes to the vegetal cytoplasm and 
marks the posterior end of the developing embryo (Le Goff et al., 
2006). Knockout of Fmn2 in the mouse produces a maternal effect 
phenotype in which females are sterile as a result of mispositioning 
of the meiotic spindle (Leader et al., 2002).
In this study, we investigate the molecular basis of the inter-
action between Spir and Capu and how the interaction infl  uences 
actin nucleation. We fi  nd that Spir and Capu interact in vivo 
as well as in vitro. Similar to Rosales-Nieves et al. (2006), 
we fi  nd that the Spir-WH2 cluster interacts with the Capu-FH2 
domain. However, we also fi  nd that the Spir-KIND domain 
binds the Capu-FH2 domain with several orders of magnitude 
higher affi  nity than the WH2 cluster. This interaction has three 
functional consequences: (1) the KIND domain potently inhib-
its actin nucleation by Capu; (2) interaction between the KIND 
domain and Capu leads to enhanced actin nucleation by Spir; 
(3) the KIND domain competes with actin fi  laments and micro-
tubules for binding to the FH2 domain of Capu. The KIND–FH2 
interaction is evolutionally conserved, as we observe the same 
results using both Drosophila and mammalian Spir and Capu 
family proteins. The direct interaction of Spir and Capu, the fact 
that the expression patterns of Spir-1 and Fmn2 exactly overlap 
in the developing nervous system (Schumacher et al., 2004), 
and the fact that their evolutionary conservation appears to be 
linked lead us to speculate that Spir and Capu function as part of 
a complex whose job is to assemble cytoskeletal landmarks for 
polarity in many systems.
Results
Spir in oogenesis
We fi  nd that full-length Spir is suffi  cient to rescue the spire 
mutant phenotype. The FlyBase Genome lists four gene products, 
which are all derived from a single Drosophila spire gene: Spir-PA, 
-PB, -PC, and -PD (GenBank/EMBL/DDBJ accession nos. 
NM_165323, NM_080115, NM_165325, and NM_165324, 
respectively). Spir-PA and -PB are  1,000 amino acids and differ 
by a 29–amino acid insert. Spir-PD is equivalent to the fi  rst 584 
amino acids of Spir-PA, whereas Spir-PC is approximately the 
C-terminal half of Spir-PA. Wellington et al. (1999) detected 
two distinct bands in Northern blots of RNA from fl  y oocytes, 
which they named Spire long form and short form (GenBank/
EMBL/DDBJ accession nos. AF184975 and AF184976). These 
correspond to Spir-PA/PB and Spir-PD, respectively. There is 
no published evidence for the expression of Spir-PC. We made 
transgenic fl  ies that express monomeric RFP (mRFP)–tagged 
full-length Spir (we refer to PA/PB as full length) in the germ-
line. The localization of Spir fusions was enriched in the oocyte 
cortex and diffuse in the oocyte cytoplasm (Fig. S1 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200706196/DC1). 
Rosales-Nieves et al. (2006) expressed GFP fusions of two 
putative spliceoforms of Spir (GFP-SpirC and GFP-SpirD) in 
Drosophila egg chambers. Consistent with our observation, they 
found both proteins associated with the oocyte cortex. They also 
observed GFP-SpirC in punctae and GFP-SpirD diffuse through-
out the oocyte. spir
1 fl  ies are putative nulls with the stereotypical 
spire phenotypes, including female sterility. Both mRFP-Spir and 
Spir-mRFP rescue female sterility in spir 
1 fl  ies, demonstrating 
that the full-length transcript is suffi  cient during oogenesis and 
that the shorter spliceoforms are not essential.
We next determined the localization of endogenous Spir in 
wild-type Drosophila egg chambers by immunofl  uorescence 
micros  copy (Fig. 1). To distinguish specifi  c from nonspecifi  c 
staining, we compared wild-type egg chambers with those of 
homozygous spir 
1 mutants (Fig. S1, B and C). From early oogenesis 
through stage 9, Spir localizes specifi  cally to the actin-rich cortex 
of the oocyte (Fig. 1, A and B). We cannot confi  rm the diffuse cyto-
plasmic localization observed in mRFP-Spir fl  ies with immuno-
fl  uorescence because we also observe it in spir 
1 fl  ies (Fig. S1 B). 
At stage 10, near the onset of cytoplasmic streaming, Spir staining 
disappears from the cortex (Fig. 1 C). Because the loss of Spir 
produces precocious cytoplasmic streaming, this result suggests 
that cytoplasmic streaming is normally triggered by the destruction 
or displacement of Spir from the oocyte cortex.
Spir and Capu interact in vivo
Spir and Capu have been shown to interact in vitro (Rosales-
Nieves et al., 2006). To determine whether these proteins interact 
in vivo, we immunoprecipitated Capu from wild-type Drosophila 
ovary lysates and probed the precipitated material with anti-
Spir antibodies. Spir coimmunoprecipitates with Capu but not 
with beads alone or beads with nonspecifi  c IgG, indicating that 
Spir and Capu are part of a protein complex in vivo (Figs. 1 D 
and S1 E).
To further examine the in vivo interaction between Spir and 
Capu, we studied their subcellular localizations when expressed 
individually or together in NIH 3T3 fi  broblasts. We compared 
Drosophila and mammalian Spir and Capu family proteins and 
used truncation mutants to map domains required for interaction. 
As we reported previously, full-length Spir localizes to punctae 
(Fig. 2 B) that correspond to the trans-Golgi network, post-Golgi 
vesicles, and recycling endosomes (Kerkhoff et al., 2001). Full-
length Capu (myc tagged) is distributed uniformly throughout the 
cytoplasm (Fig. 2 B). Coexpression of Spir together with Capu 
induces a striking change in Capu localization. Capu shifts from 
a diffuse distribution to discrete punctae that coincide with the 
lo  calization of Spir (Fig. 2 C). Using truncation mutants, we found 
that the N-terminal portion of Spir and the C-terminal portion 
of Capu are necessary for colocalization (Fig. S2 B, available 
at http://www.jcb.org/cgi/content/full/jcb.200706196/DC1). 
We then coimmunoprecipitated EGFP-Capu-FH2 with myc-Spir-
NT from cells expressing both constructs, demonstrating that 
colocalization corresponds with interaction (Fig. 2 F).
The N-terminal half of the Spir proteins, which is neces-
sary for the colocalization of Spir and Capu, contains two dif-
ferent structural motifs: one KIND domain and a cluster of four SPIR–CAPPUCCINO INTERACTION • QUINLAN ET AL. 119
WH2 domains (Fig. 2 A). Rosales-Nieves et al. (2006) mapped 
the interaction between Spir and Capu to the Capu-FH2 domain 
and the Spir-WH2 cluster. They also reported a weak interaction 
with the  150–amino acid region adjacent to the WH2 cluster 
containing the C-terminal half of the KIND domain. However, 
they did not test for an interaction with the intact KIND domain. 
We found that the KIND domain is suffi  cient for colocalization 
with an EGFP-tagged Capu-FH2 (Fig. 2). We targeted the KIND 
domain to membranes using a C-terminal Ha-Ras-CAAX motif 
(Schaber et al., 1990). When expressed in NIH 3T3 fi  bro-
blasts, KIND-CAAX localizes to the plasma membrane and to 
cytoplasmic spots (Fig. 2 D, red). Coexpression of an EGFP-
Capu-FH2 led to colocalization with the membrane-targeted 
KIND (Fig. 2 D). We could not test the WH2 domain in this 
context because the CAAX motif did not effectively drive 
WH2 localization to the plasma membrane or distinct punctae 
(unpublished data).
We also observed the colocalization of mammalian 
Spir and Capu family proteins (Spir-1 and Fmn2; Fig. S2 C). 
The Spir-1–KIND and Fmn2-FH2 domains were suffi  cient to 
mediate this interaction (Figs. 2 E and S2 C). The interaction is 
specifi  c because a KIND domain from the protein very-KIND 
(VKIND-KIND-CAAX; Mees et al., 2005) does not colocalize 
with or pull down Fmn2-FH2, nor does the FH2 domain of the 
formin mDia1 (mDia1-FH2) colocalize with or pull down Spir-1–
KIND (Fig. S2, D and E). These data suggest that the interaction 
between Spir and Capu family proteins is specifi  c and conserved.
Spir and Capu interact directly
To further examine the interaction between Spir and Capu, we 
determined the affi  nity of purifi  ed KIND for purifi  ed Capu-
FH1FH2 using fl  uorescence polarization anisotropy. Capu-FH2 
and Capu-FH1FH2 behave similarly, but the longer construct is 
more stable, so for the majority of experiments, we used Capu-
FH1FH2. We labeled an endogenous cysteine in KIND with 
AlexaFluor488 and measured changes in polarization anisotropy 
induced by Capu-FH1FH2. We determined the affi  nity by fi  tting 
the data with a quadratic binding curve (Kd = 1 ± 2 nM; Fig. 3 A). 
Figure 1.  Localization of Spir in Drosophila oocytes. (A–C) Ovaries were dissected from wild-type ﬂ  ies and processed according to Robinson and Cooley 
(1997). Spir is detected at the actin-rich oocyte cortex during midoogenesis (green, anti-Spir; red, actin detected with rhodamine-phalloidin). Examples of 
stage 9 (A) and stage 6 (B) oocytes are shown. Posterior is to the right. For comparison with spir
1 ﬂ  ies, see Fig. S1. (C) Spir is no longer at the cortex by 
stage 10b. (D) Spir and Capu interact in vivo. Spir coimmunoprecipitates with Capu from Drosophila ovary lysates. 1% of input is shown. Spir did not 
precipitate with beads alone or beads bound to nonspeciﬁ  c IgG (not depicted). The three boxes in each row are from the same exposure, moved for 
presentation. For more information, see Fig. S1 (available at http://www.jcb.org/cgi/content/full/jcb.200706196/DC1). Bars, 10 μm.JCB • VOLUME 179 • NUMBER 1 • 2007  120
To determine whether the label affected binding, we also deter-
mined the affi  nity of unlabeled KIND by using it to compete 
with the labeled protein (Kd2 = 5 ± 3 nM; Fig. 3 A, inset). 
The agreement indicates that attachment of the fluorophore 
has little effect on the interaction. The affi  nity measured using 
Capu-FH2 rather than FH1FH2 was nearly indistinguishable 
(Kd = 9 ± 6 nM; Fig. S2 F).
We found that the WH2 cluster binds weakly to Capu-
FH1FH2. The addition of Capu-FH1FH2 to AlexaFlour488-labeled 
WH2 produced a saturable change in fl  uorescence intensity, 
Figure 2.  Interaction of Spir and Capu is mediated by the KIND and FH2 domains. (A) Domain organization of Spir and Capu. (top) The central region of 
Spir proteins contains a cluster of four actin-binding WH2 motifs, which nucleate actin. The C-terminal part consists of a modiﬁ  ed FYVE zinc ﬁ  nger (mFYVE), 
which targets the protein to intracellular membranes. The adjacent Spir box (S-box) is similar to motifs found in proteins that bind Rab-3a and may also play 
a role in subcellular localization. The KIND domain is a novel motif that may function as a protein–protein interaction module. (bottom) Capu, a formin, 
contains a proline-rich region, the formin homology 1 domain (FH1), and a C-terminal formin homology 2 domain (FH2) that dimerizes and nucleates actin. 
(B–E) NIH 3T3 cells transfected with individual expression vectors (B) or cotransfected with two expression vectors (C–E) encoding the indicated proteins. 
EGFP fusion proteins are green, and the myc-tagged counterpart is localized by immunoﬂ  uorescence using anti-myc antibodies (red). (B) When expressed 
alone, full-length Capu and Capu-FH2 are diffuse throughout the cell. Spir is punctate as previously described (Kerkhoff et al., 2001). (C) When cotransfected 
with Spir, the localization of Capu shifts to a punctate pattern coinciding with Spir. (D) The Spir-KIND domain and Capu-FH2 domain are sufﬁ  cient for 
colocalization. The KIND domain is driven to membranes by a CAAX box. Capu-FH2 is found concentrated at these same structures. (E) These interactions 
are conserved in mammalian proteins. Here, we show the colocalization of Spir-1–KIND and Fmn2-FH2 (Fig. S2 C, available at http://www.jcb.org/cgi/
content/full/jcb.200706196/DC1). Insets are magniﬁ  ed (2.3 times) images of the boxed areas. (F) Coimmunoprecipitation of EGFP-Capu-FH2 and 
myc-Spir-NT from NIH 3T3 cells expressing these constructs with a myc antibody. Bars, 10 μm.SPIR–CAPPUCCINO INTERACTION • QUINLAN ET AL. 121
so we used fl  uorescence intensity as a metric for binding. We de-
termined an affi  nity of 2.4 ± 0.9 μM (Fig. 3 B), which is roughly 
three orders of magnitude weaker than the affi  nity of KIND for 
Capu-FH2. We could not measure the affi  nity of unlabeled WH2 
by competition because higher concentrations of the WH2 domain 
produced dose-dependent light scattering. This probably refl  ects 
aggregation caused by the highly charged WH2 cluster.
We found that the stoichiometry of the KIND–FH2 complex 
is 2:2 (two KIND monomers/one FH2 dimer). Using velocity 
sedimentation and equilibrium centrifugation, we fi  rst determined 
that the KIND domains from human Spir-1 and Drosophila 
Spir are both monomeric and highly asymmetric (Fig. 4, A–C). 
To measure the stoichiometry of the complex, we combined 
AlexaFluor488-labeled Capu-FH1FH2 with KIND at three differ-
ent ratios and spun the mixtures to equilibrium at multiple speeds. 
We determined the equilibrium distribution of Capu-FH1FH2 
by measuring the absorbance of the attached fl  uorophore. These 
data were best fi  t by a single-species model with a molecular 
mass close to that predicted for two KIND domains plus one 
Capu-FH1FH2 dimer (predicted, 223.6 kD vs. measured, 225 kD; 
Fig. 4 D). The fact that the data fi  t a single-species model is 
consistent with a high affi  nity interaction between KIND and 
Capu-FH1FH2. We detected no evidence of the Capu-FH1FH2 
dimer either free or bound to a single KIND domain.
Functional consequences 
of the Spir–Capu interaction
Spir family proteins inhibit actin nucleation by Capu family formins 
(Fig. 5 and Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200706196/DC1). Because Spir binds the nucleation 
domain of Capu, we used pyrene-actin fl  uorescence assays to 
determine the effect on Capu activity. Both Capu-FH2 and Capu-
FH1FH2 promote rapid actin fi  lament assembly. The addition 
of KIND caused a dose-dependent decrease in nucleation activity 
(Figs. 5 A and S3 A). Because of local concentration effects, the 
addition of a weak interaction to a stronger one can have an 
effect on overall affi  nity. Thus, we also tested a mutant form of 
NTSpir (NTSpir[A*B*C*D*] from Quinlan et al., 2005), which 
includes both the KIND domain and the WH2 cluster but nucleates 
only very weakly (Fig. S3 B). By plotting the rate of nucleation 
versus the concentration of KIND (Figs. 5 B and S3 D) and fi  tting 
the data with a quadratic binding curve, we determined inhibi-
tion constants (Ki). In all cases, Spir inhibited FH2-dependent 
nucleation by >90% and with comparable apparent affi  nities 
(5–10 nM; Fig. 5 B). These Kis agree well with the Kd measured 
by polarization anisotropy, but, from our data, we cannot deter-
mine whether the binding of one or two KIND domains is required 
for inhibition. We observe the same effect with the mammalian 
proteins (Fig. S3 C). The Kd and Ki of the Spir-1–KIND–Fmn2-
FH2 interaction are higher than observed with Drosophila isoforms 
but, in general, agree with each other (300 ± 60 and 190 ± 40 nM; 
Figs. S2 G and S3 E).
Neither Drosophila nor mammalian KIND affects spontane-
ous actin assembly (Fig. S4, A and B; available at http://www.jcb
.org/cgi/content/full/jcb.200706196/DC1), demonstrating that the 
effect is specifi  c to the activity of the Capu-FH2 domain. Also, 
Spir-1–KIND had no effect on actin nucleation by FH2 domains 
from Diaphanous family formins mDia1 and mDia2 (Fig. S4 C), 
indicating that the inhibitory effect of Spir-KIND domains is 
specifi  c to Capu family formins.
Capu does not inhibit actin nucleation by Spir (Fig. 5 C). 
To assess the effect of Capu on Spir-dependent nucleation, we 
mutated Capu-FH1FH2. Mutating Ile-706 to Ala (analogous to 
Ile-1431-Ala in Saccharomyces cerevisiae Bni1; Xu et al., 
2004) almost completely abolishes nucleation activity. The 
addition of Capu-FH1FH2(I706A) to NTSpir enhanced nucle-
ation activity (Fig. 5 C, green vs. blue traces). The effect increased 
with increasing concentrations of Capu-FH1FH2(I706A) until 
approximately equimolar concentrations of proteins were present. 
Figure 3. Binding  afﬁ  nities of direct interactions between Spir and Capu. 
(A) Polarization anisotropy of 10 nM AlexaFluor488-labeled KIND in the 
presence of the Capu-FH1FH2 domain. By ﬁ  tting the concentration-dependent 
change in anisotropy to a quadratic binding curve, we determined a 
dissociation equilibrium constant of 1 ± 2 nM. (inset) Competition of 
ﬂ   uorescently labeled KIND with unlabeled KIND. We mixed 10 nM 
  AlexaFluor488-labeled KIND and 50 nM Capu-FH1FH2 with varying 
concentrations of unlabeled KIND. Fitting the decrease in anisotropy to a 
competition binding curve (see Materials and methods) yields a dissociation 
equilibrium constant of 5 ± 3 nM. Error bars represent SD. (B) The afﬁ  nity 
of 20 nM AlexaFluor488-labeled WH2 was measured by ﬁ  tting a quadratic 
binding curve to concentration-dependent intensity changes induced by 
adding Capu-FH1FH2. The Kd is 2.4 ± 0.9 μM. Error bars are smaller than 
the symbols.JCB • VOLUME 179 • NUMBER 1 • 2007  122
Further increases in Capu-FH1FH2(I706A) concentration de-
creased activity. This dose response is consistent with an 
enhance  ment mechanism dependent on the dimerization of Spir 
via the KIND–FH2 interaction. We observed the same effect with 
mammalian isoforms (unpublished data). Although we detect 
binding between the two domains, the Capu-FH1FH2 domain has 
no effect on actin nucleation by the WH2 cluster alone (Fig. 5 C, 
inset), confi  rming that enhancement depends on interaction between 
the KIND and FH2 domains.
When active Capu-FH1FH2 and NTSpir are combined, 
the measured nucleation rate refl  ects a combination of inhibi-
tion and enhancement activity (Fig. 5 D). For example, the rate 
of polymerization in the presence of 100 nM Capu-FH1FH2 
and 250 nM NTSpir falls between the rates of either nucleator 
alone. Nucleation by 100 nM Capu-FH1FH2 has virtually no lag, 
whereas nucleation by 250 nM NTSpir has a marked lag ( 30 s). 
When the two are combined, a long lag is observed that is con-
sistent with the potent inhibition of Capu-FH1FH2 nucleation 
Figure 4.  Two KIND domains bind each Capu dimer. (A and B) We determined that KIND domains from Drosophila Spir and human Spir-1 are monomeric 
using equilibrium centrifugation. We measured the solution molecular weights of puriﬁ  ed KIND (A) and Spir-1–KIND (B) as described in Materials and 
methods. We spun samples to equilibrium at 10,000 (open circles), 14,000 (closed circles), and 20,000 rpm (open squares). Symbols are data points; 
lines represent the best ﬁ  t to a single species model. Residuals for each dataset are shown below. In both cases, the apparent molecular weight by centrifugation 
was slightly higher than the predicted monomer molecular weight, suggesting a possible weak tendency to self-associate. By ﬁ  tting the ultracentrifugation 
data with a monomer-dimer equilibrium model, we placed lower bounds on the dissociation equilibrium constants for dimerization. For KIND, the Kd for 
  dimerization is at least 92 μM, and, for Spir-1–KIND, it is >530 μM. Neither dataset was well ﬁ  t by a single-species model with the molecular weight of 
a KIND homodimer. (C) The KIND domain is highly asymmetric. We measured the sedimentation coefﬁ  cient, Stokes radius, and aspect ratio of KIND by 
  velocity sedimentation. Both oblate and prolate ellipsoids with an aspect ratio of 1:8 ﬁ  t the data. The molecular weight measurement agrees with that found by 
equilibrium sedimentation (44.7 vs. 44.6 kD). Because this value is larger than expected, we conﬁ  rmed that the actual molecular mass is 37.7 kD with mass 
spectometry. Velocity sedimentation analysis of Spir-1–KIND indicates a 1:8 aspect ratio as well (not depicted). (D) We measured the solution molecular 
weight of three molar ratios of AlexaFluor488-labeled Capu-FH1FH2 and KIND (1 [Capu dimer]:1 [KIND], 1:2, and 1:4). We spun samples to equilibrium 
at 5,000 (open circles), 7,000 (closed circles), and 14,000 rpm (open squares) and measured protein concentration as a function of radius by absorbance 
at 500 nm to track the AlexaFluor488-labeled protein. The apparent molecular mass of the single species is 225 kD, which is very close to the predicted 
mass of 223.6 kD (the sum of one Capu-FH1FH2 dimer [134 kD] plus two KIND molecules [Mapp = 2 × 44.6 kD]). We found that Capu-FH1FH2 alone 
is unstable under the same conditions (not depicted). Therefore, in the case in which there was excess Capu-FH1FH2 (1:1), we believe that unbound 
Capu-FH1FH2 precipitated, leaving only the complex to be detected. Conditions: buffer, 50 mM KCl, 10 mM Hepes, pH 7, 1 mM TCEP, and 0.01% sodium azide; 
temperature, 24°C.SPIR–CAPPUCCINO INTERACTION • QUINLAN ET AL. 123
(Fig. 4 D, inset). Rosales-Nieves et al. (2006) did not observe 
such synthetic activity when they combined Capu-FH2 and SpirD 
(equivalent to NTSpir). One possible explanation is that the 
KIND domain was not folded correctly in these experiments. 
When we treat NTSpir with denaturant (e.g., GnHCl) or the 
KIND domain is absent (WH2 alone), Spir retains nucleation 
activity, but Spir and Capu do not interact in the polymerization 
assay (Fig. 5 C, inset; and not depicted).
Spir-KIND competes with microtubules for binding to 
Capu-FH2 (Fig. 6; Rosales-Nieves et al., 2006). The FH2 domain 
of formins is known to bind microtubules in vitro and in vivo 
(Wallar and Alberts, 2003). Rosales-Nieves et al. (2006) reported 
that Capu-FH2 cross-links actin and microtubules and that this 
activity is modulated by Spir. We also assessed the ability of 
Capu family formins to bind microtubules and tested the effect 
of the KIND domain on this interaction. We found that both 
Drosophila Capu and Fmn2 cosediment with microtubules 
(Fig. S5 A, available at http://www.jcb.org/cgi/content/full/
jcb.200706196/DC1), whereas KIND domains do not detectably 
bind microtubules (Fig. S5 B). We confi  rmed that Capu-FH1FH2 
cross-links micro tubules by examining solutions of taxol-stabilized 
micro  tubules mixed with Capu-FH1FH2 by fl  uorescence micros-
copy and by per forming polymerization assays under conditions 
that require a factor that stabilizes or cross-links tubulin nuclei 
Figure 5.  Interaction between Spir and Capu affects actin nucleation. (A) The Spir-KIND domain inhibits actin nucleation by Capu family formins. We induced 
polymerization by mixing pyrene-labeled actin with Mg
2+, K
+, and Capu-FH1FH2. The addition of KIND to Capu-FH1FH2 before mixing with actin potently 
inhibited nucleation activity in a dose-dependent manner. Protein concentrations were as follows: actin, 4 μM (5% pyrene labeled); Capu-FH1FH2, 10 nM; 
KIND, as indicated. (B) Plot of nucleation rates (calculation shown in Fig. S3 D, available at http://www.jcb.org/cgi/content/full/jcb.200706196/DC1) 
versus concentration of KIND added. Data were ﬁ  t with a quadratic binding curve. The inhibition constants for Capu-FH2 (Ki = 5 ± 1 nM), Capu-FH1FH2 
(Ki = 10 ± 2 nM), and NTSpir[A*B*C*D*] (Ki = 6 ± 6 nM) are similar, indicating that the effect of KIND is independent of the Capu-FH1 domain and 
Spir-WH2 cluster. (C) Capu enhances actin nucleation by Spir. We mixed several concentrations of a nucleation-incompetent mutant of Capu-FH1FH2 
(Capu-FH1FH2(I706A)) with the N-terminal half of Spir (NTSpir), which contains the KIND domain and four WH2 domains (only three concentrations are 
shown for clarity). Nucleation activity of NTSpir was increased by Capu-FH1FH2(I706A) until the proteins were approximately equimolar, and then activity 
decreased. (inset) Capu-FH1FH2(I706A) does not enhance the activity of the WH2 cluster alone, indicating that an interaction between the KIND domain 
and the formin is necessary. Protein concentrations were as follows: actin, 4 μM (5% pyrene labeled), NTSpir and WH2, 250 nM; Capu-FH1FH2(I706A), 
as indicated. (D) Capu and Spir affect each other’s actin-nucleation activity. 100 nM Capu-FH1FH2 was mixed with a range of NTSpir concentrations. 
The activity is not the sum of the individual components. Baseline activities are shown for comparison: 100 nM Capu-FH1FH2 (red) and 250 nM NTSpir (green). 
(inset) Expanded view of the early time shows a lag when Spir and Capu are mixed that is absent for Capu alone.JCB • VOLUME 179 • NUMBER 1 • 2007  124
(Fig. S5, E and F; Westermann et al., 2005). The addition of 
KIND to Capu and microtubules decreased microtubule binding 
by Capu in a dose-dependent manner (Fig. 6 A). About 2.5 μM 
KIND is necessary to compete half of the Capu-FH1FH2 away 
from 2 μM of polymerized tubulin, indicating that microtubules 
and KIND bind Capu-FH1FH2 with similar affi  nity. By fi  tting 
the data to a competition binding curve, we measured an affi  nity 
of Capu for microtubules of <1 nM (Fig. 6 C). We found no 
difference in competition with NTSpir versus KIND alone, 
indicating that the WH2 cluster does not contribute measurably 
to this inhibitory interaction (Fig. S5 C).
Spir-KIND also regulates actin bundling by Capu (Fig. 6). 
In addition to binding barbed ends, some formins also bind the 
sides of actin fi  laments and bundle them (Harris et al., 2004; 
Michelot et al., 2005). To test for actin bundling, we mixed 
0.5 μM Capu-FH1FH2 with 2 μM phalloidin-stabilized actin. 
Figure 6.  The KIND domain, microtubules, and actin bind Capu-FH1FH2 competitively. (A) Gels of cosedimentation assays show that the majority of the 
Capu-FH1FH2 cosediments when 0.5 μM Capu-FH1FH2 and 2 μM of stabilized microtubules are combined and centrifuged (left-most lanes of each gel). 
The addition of increasing amounts of KIND (0.0625, 0.125, 0.25, …16 μM) leads to the dissociation of Capu-FH1FH2 from microtubules, resulting in 
decreasing amounts of the formin in the pellet. (B) Gels of cosedimentation assays show that the majority of the Capu-FH1FH2 cosediments when 0.5 μM 
Capu-FH1FH2 and 2 μM of stabilized actin ﬁ  laments are combined and centrifuged (left-most lanes of each gel). The addition of increasing amounts of KIND 
(0.0625, 0.125, 0.25, …16 μM) leads to the dissociation of Capu-FH1FH2 from actin, resulting in decreasing amounts of formin in the pellet. (C) Gels 
were quantiﬁ  ed with Sypro-Red staining. Circles are Capu-FH1FH2 in the supernatant; squares are from the pellet. It takes  2.5 μM KIND to compete 
about half of the Capu-FH1FH2 away from microtubules because Capu-FH1FH2–microtubule interaction is very high afﬁ  nity, as determined by ﬁ  tting the 
data to a competition equation (Kd = 0.5 ± 0.1 nM). Only  0.5 μM KIND is required to compete about half of the Capu-FH1FH2 away for actin, indicating 
that the afﬁ  nity of Capu-FH1FH2 for actin is lower than that for microtubules, although still tight (Kd = 7 ± 1 nM). Only the data that meet the assumptions 
(solid symbols) were used for the ﬁ  t (see Materials and methods). (D) Actin cross-linking assay. 2 μM of ﬁ  lamentous actin plus 0.5 μM Capu-FH1FH2 or α-actinin 
were centrifuged at 16,000 g for 5 min. The supernatants and pellets were separated and analyzed by SDS-PAGE. Lines are for ease of comparison. 
The samples were all run on the same gel. Actin is found in the pellet in the presence of Capu-FH1FH2 and α-actinin, a known actin cross-linker.SPIR–CAPPUCCINO INTERACTION • QUINLAN ET AL. 125
We observed bundles directly by fl  uorescence microscopy (Fig. 
S5 G) and indirectly with a low speed pelleting assay, in which 
only cross-linked networks or bundles of actin sediment (Fig. 6 D; 
Harris et al., 2006). The majority of the actin was bundled in the 
low speed pelleting assay. As a control, we used 0.5 μM α-actinin, 
a known actin cross-linker. Actin is in the supernatant when alone 
and in the pellet when α-actinin is added. Examination of the actin 
showed tight bundling in the presence of Capu-FH1FH2 similar to 
other formins and distinct from the loose networks created by 
α-actinin (Fig. S5 G; Wachsstock et al., 1993; Harris et al., 2006). 
Capu-FH1FH2 bundles more effectively than α-actinin, most 
likely refl  ecting a difference in off rates. We measured the effect of 
Spir on actin bundling by mixing 0.5 μM Capu-FH1FH2 with 
2 μM actin and a range of concentrations of KIND or NTSpir. 
We then performed high speed cosedimentation assays and low 
speed cross-linking assays. We quantifi  ed Capu-FH1FH2 in the 
supernatants and pellets as a function of KIND concentration. 
By fi  tting the data to a competition binding curve, we found that the 
Kd of  Capu for the sides of actin fi  laments is 7 ± 1 nM (high speed) 
or 6 ± 2 nM (low speed; Fig. 6, B and C; and not depicted).
Discussion
The spire and cappuccino genes have been linked since their 
discovery in a genetic screen 17 yr ago. We fi  nd that the KIND 
domain of Spir binds with high affi  nity to the Capu-FH2 domain 
at a stoichiometry of 2:2 (two KIND monomers to one FH2 dimer). 
We also fi  nd that the WH2 cluster of Spir interacts with Capu-
FH2 but that this interaction is three orders of magnitude weaker 
than that between the Capu-FH2 and the KIND domain. Although 
we detect binding between the two domains, the Capu-FH2 
domain has no direct effect on actin nucleation by the Spir-WH2 
cluster. However, if the KIND domain is present and correctly 
folded, binding of the FH2 dimer increased nucleation activity 
of the WH2 cluster. On the other hand, the KIND domain potently 
inhibits actin nucleation by the Capu-FH2 domain. Constructs 
containing both the KIND and WH2 cluster do not enhance 
the inhibition of Capu-FH2–mediated actin nucleation or micro-
tubule bundling over that observed for the KIND domain alone. 
For these reasons, we propose that the KIND–FH2 interaction is 
more physiologically relevant than the WH2–FH2 interaction. 
Additional structural and functional studies of the KIND domain 
are required to determine how many KIND domains are re-
quired to inhibit actin nucleation and to compete for actin and 
microtubule binding.
We originally identifi  ed the KIND module as a conserved 
region in the N-terminal half of Spir proteins (Ciccarelli et al., 
2003) and named the region based on its sequence similarity to 
the C-lobe of the protein kinase fold (Ciccarelli et al., 2003). 
The KIND domain is found only in metazoa, and its consensus 
sequence lacks catalytic residues required for kinase activity. 
Because the substrates of protein kinases interact with α-helical 
regions in the C-lobe (Knighton et al., 1991; Tanoue and Nishida, 
2002) we hypothesized that the KIND domain evolved from 
a functional kinase into a protein–protein interaction domain. 
The discovery that the Spir KIND domains bind specifi  cally to 
Capu family FH2 domains supports this hypothesis.
What role do Spir and Capu play in oogenesis? Spir dis-
appears from the oocyte cortex at stage 10, when rapid streaming 
normally begins and its absence in spire mutant fl  ies leads to 
premature streaming. This strongly suggests that Spir plays an 
inhibitory role in rapid streaming. We do not yet know whether 
endogenous Capu has the same restricted temporal pattern 
observed for Spir. This information will be essential to under-
standing the nature of the Spir–Capu complex and its role dur-
ing oogenesis. We fi  nd that Spir and Capu interact in the oocyte, 
and Rosales-Nieves et al. (2006) found that GFP fusions of 
these protein both exist at the oocyte cortex, placing them in an 
ideal location to coordinate actin and possibly anchor micro-
tubules. Rapid streaming is, in part, characterized by bundling and 
movement of microtubules. Capu bundles microtubules, which 
is an activity regulated by Spir. If Spir is removed at stage 10 
but Capu remains, Capu could play a role in reorganizing the 
microtubule cytoskeleton and possibly coordinating it with the 
actin cytoskeleton. A complete understanding of how Spir and 
Capu achieve this coordination depends on knowing when 
and how the Spir–Capu complex is regulated.
Capu and other members of the formin family nucleate 
de novo actin fi  lament assembly and remain associated with 
elongating barbed ends of newly formed fi  laments (Pring et al., 
2003; Quinlan et al., 2005). The activity of most formin family 
proteins is regulated by an autoinhibitory interaction between 
an N-terminal sequence (the Diaphanous inhibitory domain [DID]) 
and a C-terminal sequence (the Diaphanous autoinhibitory domain 
[DAD]). Small G proteins of the Rho family stimulate nucle-
ation activity by binding to the DID domain and disrupting its 
interaction with DAD. However, Capu family formins lack both 
DID and DAD domains (Higgs and Peterson, 2005). In fact, 
Rosales-Nieves et al. (2006) did not observe autoinhibition 
when combining the N terminus of Capu with the FH2 domain, 
as has been observed for mDia1 (Li and Higgs, 2003). Our results 
argue strongly that Capu activity is regulated in trans by inter-
action with Spir.
The mechanism of actin nucleation by Spir is very different 
from that of formins like Capu. Spir binds four actin monomers 
using four closely apposed binding sites and then assembles them 
into a fi  lament nucleus. After nucleation, Spir proteins remain 
associated with the slow-growing pointed end of the new fi  lament. 
If Spir and Capu always function together as a single fi  lament-
forming complex, we suggest that their activities might synergize. 
One intriguing possibility is that Spir nucleates fi  laments whose 
free barbed ends are then handed off to Capu. Such a mechanism 
would enable the independent control of fi  lament nucleation and 
barbed end binding. The tight binding that we measure suggests 
that Spir and Capu may not dissociate upon nucleation but that 
actin and microtubules do bind competitively. This idea begs two 
important questions: (1) Does the activation of Capu require the 
complete dissociation of Spir, or can the two proteins function 
together as a single fi  lament–forming unit? (2) How is the 
Spir–Capu interaction modulated by upstream signaling systems? 
Recent data implicate the GTPase Rho as a regulator of Spir–Capu 
interaction in Drosophila (Rosales-Nieves et al., 2006). The 
Spir–Capu interaction is evolutionally conserved, but whether or 
not this mode of regulation is conserved remains to be tested.JCB • VOLUME 179 • NUMBER 1 • 2007  126
Materials and methods
Fly strains and immunoﬂ  uorescence
Both Canton-S and w
iso ﬂ  ies were used as wild type (provided by R. Bainton, 
University of California, San Fransisco, San Fransisco, CA). spir
1,cn
1,bn
1/
Cyo,I(2)DTS513
1 and b
1,pr
1,spir
2F,cn
1/CyO ﬂ  ies were obtained from 
T. Schupbach (Bloomington Drosophila Stock Center, Indiana University, 
Bloomington, IN). Transgenes were cloned into a pUASp vector and expressed 
in the germline with VP16nos:Gal4 or pCog:Gal4; NGT40:Gal4; VP16nos:
Gal4 triple maternal driver lines (provided by L. Cooley, Yale, New Haven, CT). 
For immunoﬂ  uorescence, they were ﬁ  xed and stained according to methods 
described by Robinson and Cooley (1997). For actin visualization, ovaries 
were incubated in 1–2 U rhodamine-conjugated phalloidin (Invitrogen). For Spir 
immunolocalization, ovaries were incubated with  1 μg/ml antibody, 
and AlexaFluor488-conjugated goat anti–rabbit secondary antibody 
(Invitrogen) was used at a 1:1,000 dilution. Samples were mounted in 
ﬂ  uorescence mounting medium (DakoCytomation). For live imaging, ovaries 
were dissected and teased apart under Halocarbon 700 oil (Sigma-Aldrich) 
at room temperature. In both cases, images were collected with a plan-
Neoﬂ  uor 25× 0.8 NA objective lens on a confocal microscope (LSM 510 
META; Carl Zeiss MicroImaging, Inc.) with its proprietary software. Final 
rotations, cropping, and conversion to TIF format were performed in ImageJ 
(National Institutes of Health).
DNA constructs
Standard PCR and cloning methods were used to make DNA constructs.
Cell culture and transfections
NIH 3T3 mouse ﬁ  broblasts were cultured in DME supplemented with 10% FCS, 
glutamate, penicillin, and streptomycin at 37°C in a CO2 (10%) incubator. 
The cells were transiently transfected with eukaryotic expression vectors 
with LipofectAMINE (Invitrogen). Immunoﬂ  uorescence was performed as 
described previously (Otto et al., 2000). Cells were assayed 36 h after 
transfection. 5 μg/ml myc 9E10 mouse monoclonal antibodies (Santa 
Cruz Biotechnology, Inc.) and anti-TRITC–conjugated donkey anti–mouse 
(1:200; Dianova) were used. Fixed samples were mounted in a solution of 
15 g Moviol, 60 ml PBS, 30 ml glycerol, and 2.25 g N-propyl-gallate. 
Images were collected with a 100× NA 1.3 oil U-V-I objective lens (Leica) 
on a ﬂ  uorescence microscope (DMIRBE; Leica). Recordings were made 
with a camera (C4742-95; Hamamatsu) using Openlab 4.0.4 software 
(Improvision). Images were contrast enhanced and saved as TIF ﬁ  les using 
Openlab. All work was performed at room temperature.
Protein expression and puriﬁ  cation
His-tagged proteins pQE-80L-m-Fmn2-FH2 (Fmn2-FH2), pQE-80L-hu-Spir1-
KIND (Spir-1–KIND), pET-20b
+-p150-Spir-KIND (KIND), and pET-20b
+-
p150-NTSpir (NTSpir) were expressed in Escherichia coli BL-21(DE3)pLysS 
cells. Cells were grown at 37°C to an optical density (A600) of 0.6–0.8, 
induced with 0.25 mM IPTG, and harvested 3 h later. pET-20b
+-p150-
Spir-WH2 (WH2) and pET-20b
+-p150-Spir-KCK-WH2(C459S) (KCK-WH2) 
were harvested after only 1.5 h. pET-20b
+-Capu-FH2 (Capu-FH2) and 
pET-20b
+-Capu-FH1FH2 (Capu-FH1FH2) were expressed in E. coli Rosetta 
bacteria (Novagen). Cells were grown at 37°C to an optical density (A600) 
of 0.4–0.6, cooled to 21°C, induced with 0.1 mM IPTG, and grown over-
night. His-tagged proteins were puriﬁ  ed with BD Talon resin (CLONTECH 
Laboratories, Inc.), and most were further puriﬁ  ed by anion exchange 
(monoQ) chromatography. See Table I for a summary of constructs and their 
extinction coefﬁ  cients.
GST-tagged protein E. coli Rosetta bacteria was transformed with 
GST fusion protein expression vectors (GST-Spir1-KIND and GST-VKIND-
KIND). Cells were grown at 37°C to an optical density (A600) of 0.6–0.8, 
induced with 0.1 mM IPTG, and incubated at 21°C overnight. After centrif-
ugation, the bacteria were suspended in TBS-Tween buffer (150 mM NaCl, 
10 mM Tris-HCl, pH 7.4, and 0.1% Tween) and sonicated. The soluble extract 
was incubated with glutathione–Sepharose 4B beads (GE Healthcare) for 2 h 
at 4°C. The beads were washed twice with TBS-Tween buffer and resuspended 
in the same buffer for pull-down assays.
Immunoprecipitation
Immunoprecipitation from ﬂ  y ovary was performed according to the methods 
of Rosales-Nieves et al. (2006;  100 ﬂ  ies were used for each condition). 
Immunoprecipitation from tissue culture cells was performed as follows: 36 h 
after transfection, NIH 3T3 cells were lysed with immunoprecipitation 
lysis buffer (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 2 mM 
EGTA, 10% glycerol, 0.1% NP-40, 2 μg/ml leupeptin, 2 μg/ml aprotinin, 
1 mM PMSF, 10 mM NaF, and 0.2 mM Na3VO4). Anti–myc 9E10 mono-
clonal antibodies (Santa Cruz Biotechnology, Inc.) were added to the cleared 
cell lysate to a ﬁ  nal concentration of 5 μg/ml and incubated for 1 h on ice. 
Protein G–agarose (Roche) was added, and the sample was rotated for 
150 min at 4°C. The beads were washed twice with immunoprecipitation 
lysis buffer, and bound proteins were analyzed by Western blotting.
GST pull-down experiments were performed as follows: 1–2 μg 
GST/GST-VKIND-KIND/GST-hu-Spir-1-KIND/GST-hu-Spir-1-KIND-WH2 fusion 
protein was coupled to 50 μl glutathione–Sepharose beads and washed 
twice with pull-down buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM 
EDTA, 0.1% NP-40, and 10% glycerol). NIH 3T3 ﬁ  broblasts transiently 
expressing EGFP-mDia1-F2 and EGFP-m-Fmn2-FH2 were lysed with pull-down 
buffer for 40 min at 4°C. Cleared lysate was incubated with the glutathione–
Sepharose beads for 2 h. The beads were gently washed ﬁ  ve times in 
pull-down buffer and boiled in SDS sample buffer. The samples were analyzed 
by Western blotting.
Protein labeling
Acanthamoeba actin was labeled with pyrene iodoacetamide as described 
previously (Cooper et al., 1983). Puriﬁ  ed KIND (human and Drosophila) 
was incubated with a 1–2.5-fold molar excess of AlexaFluor488-maleimide 
(Invitrogen) in labeling buffer (50 mM KCl, 50 μM Tris(2-carboxyethyl) 
phosphine [TCEP], and 10 mM Hepes, pH 7) for 30 min at 24°C. The re-
action was quenched by the addition of 10 mM DTT. Free dye was removed 
by gel ﬁ  ltration and veriﬁ  ed by SDS-PAGE. Protein concentration was 
determined by absorbance at 280 nm using molar extinction coefﬁ  cients 
(human, 22,620 cm
−1; Drosophila, 17,452 cm
−1; Table I) and correcting 
for dye absorbance (0.11*A496). The concentration of incorporated dye 
was determined by absorbance at 496 nm using an extinction coefﬁ  cient 
of 71,000 cm
−1. The labeling efﬁ  ciency of Spir-1–KIND varied from 85 to 
94% at all dye/protein ratios above 1:1, suggesting that Spir-1–KIND 
contains a single accessible and reactive cysteine. The labeling efﬁ  ciency 
of KIND was >100% at dye/protein ratios above 1:1. Therefore, we 
underlabeled KIND (15–45%) to increase the probability of only labeling 
one cysteine per protein.
To label Capu-FH1FH2, we added a Lys-Cys-Lys to the C terminus. 
To label the WH2 cluster, we ﬁ  rst mutated the only native cysteine in WH2 to 
serine and then engineered a Lys-Cys-Lys sequence onto the N terminus of the 
polypeptide. Mutation and labeling had no effect on the actin nucleation 
activity of either construct. We followed the labeling protocol used for the 
KIND domains except that the labeling conditions were between one- and 
twofold molar excess of AlexaFluor488-maleimide for 5–10 min at 24°C. 
Both proteins were labeled  100%.
Analytical ultracentrifugation
Extinction coefﬁ  cients for Spir-1–KIND and Fmn2-FH2 were determined by 
spinning puriﬁ  ed, recombinant proteins at 40,000 rpm in an analytical 
ultracentrifuge (XL-I; Beckman Coulter). Proteins and buffer blanks were 
loaded into two-channel centrepieces and spun until the meniscus was 
depleted of protein. We then measured the relative index of refraction and 
the absorbance at 280 nm as a function of radius. We determined protein 
concentration from the index of refraction (assuming 3.3 mg/ml/fringe 
displacement) and compared it with absorbance at 280 nm (assuming an 
optical path length of 1.2 cm).
Table I. Summary of puriﬁ  ed proteins used in biochemical assays (all 
His tagged)
Construct name Residues Extinction coefﬁ  cient
Drosophila isoforms
 NTSpir 1–520 25,575
a cm
−1
 KIND 1–327 17,452
a,b cm
−1
 WH2 366–482 15,220
b cm
−1
 Capu-FH2 573–1,058 53,760
a cm
−1
 Capu-FH1FH2 467–1,058 75,200
a cm
−1
Mammalian isoforms
 Spir-1–KIND 2–271 22,620
c cm
−1
 Fmn2-FH2 1,124–1,567 25,445
c cm
−1
aQuantitative SDS-PAGE with Sypro-Red staining.
bComparison of absorbance at 280 nM of native protein with protein denatured 
in 6 M GnHCl.
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Solution molecular weights were determined by spinning samples 
to equilibrium in an analytical ultracentrifuge (XL-I; Beckman Coulter) and 
measuring protein concentration as a function of radius. For individual pro-
tein, we used three different concentrations ( 0.5, 0.25, and 0.125 mg/ml). 
For KIND and Capu-FH1FH2 together, we used three molar ratios of 
AlexaFluor488-labeled Capu-FH1FH2 and KIND (1 [Capu dimer]:1 
[KIND], 1:2, and 1:4). We spun samples to equilibrium at three speeds 
and measured protein concentration as a function of radius by absorbance 
at 280 or 500 nm to track the ﬂ  uorophore. We then globally ﬁ  t all of the 
sedimentation curves obtained at different concentrations and speeds (nine 
datasets) to different models (Johnson et al., 1981) using Winnonln (J. Lary 
and D. Yphantis, National Analytical Ultracentrifugation Facility, Storrs, 
CT) or Ultrascan (B. Demeler, University of Texas Health Science Center, 
San Antonio, TX).
Pyrene actin assembly assays
We performed pyrene actin assembly assays as described previously 
(Zalevsky et al., 2001). In brief, we used 4 μM Acanthamoeba actin doped 
with 5% pyrene-labeled actin. Ca
2+-actin was converted to Mg
2+-actin be-
fore each reaction by a 2-min incubation with 50 μM MgCl2 and 200 μM 
EGTA. All components except actin were combined before the initiation of 
  polymerization. All polymerization reactions contained 50 mM KCl, 1 mM 
MgSO4, 1 mM EGTA, and 10 mM imidazole, pH 7.0. Pyrene ﬂ  uorescence 
was measured by a multifrequency ﬂ  uorometer (K2; ISS), and data were 
analyzed using KaleidaGraph (Synergy Software) and in-house software.
Polarization anisotropy
Low concentrations (10–20 nM) of the protein labeled with AlexaFluor488 
(Spir-1–KIND, KIND, or WH2) was mixed with unlabeled target protein 
(Fmn2-FH2, Capu-FH1FH2, or Capu-FH2) at the indicated concentrations 
in KMEH (50 mM KCl, 20 mM Hepes, pH 7.0, 1 mM MgCl2, 1 mM EGTA, 
and 1 mM TCEP), and polarization anisotropy was measured at 24°C using 
a multifrequency ﬂ  uorometer (K2; ISS) and analyzed using KaleidaGraph 
(Synergy Software). Under the conditions used in our study, anisotropy is 
a measure of the rotational mobility of the labeled protein. We excited the 
ﬂ  uorophore with plane polarized light at 488 nm (with a 488-nm bandpass 
ﬁ  lter) and measured emission at 520 nm (KV500 and KV520 ﬁ  lters) at 
polarizations both parallel (I∣∣) and perpendicular (I⊥) to the excitation light. 
We simultaneously monitored total intensity to ensure that the quantum ef-
ﬁ  ciency of the ﬂ  uorophore was independent of the protein complex. In the 
case of labeled WH2, the intensity changed in a concentration-dependent 
saturable manner, so we used this value instead of anisotropy. We deter-
mined equilibrium dissociation constants using a quadratic binding model 
as previously described (Zalevsky et al., 2001).
In competition binding experiments, we determined the dissociation 
constant of the unlabeled protein by ﬁ  tting anisotropy data to the function 
(Vinson et al., 1998)
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where Kd2 is the dissociation constant of the nonﬂ  uorescent competitor, [C] is 
the total concentration of the competitor, and [Ro] is the concentration of free 
Capu-FH1FH2 when [C] = 0. For this analysis, [Ro] and Kd are determined 
from the anisotropy in the absence of competitor, and Kd2 is determined 
from ﬁ  tting the above equation to experimental data. This function is an 
approximation and is only valid when unlabeled KIND and formin are in 
excess over the labeled protein. These conditions were met in our competition 
binding experiments.
Microtubule-binding assay
Puriﬁ  ed porcine brain tubulin was provided by A. Carter (laboratory of R. Vale, 
University of California, San Fransisco, San Fransisco, CA). Microtubules 
were stabilized with taxol, and all experiments were performed in KMEH. 
Capu-FH1FH1, Fmn2-FH2, KIND, and Spir-1–KIND were cleared by centri-
fugation at 100,000 g for 20 min at 24° C before each assay. Microtubules 
were added at four- to eightfold molar excess. Samples were incubated for 
15 min and centrifuged at 100,000 g for 10 min at 24°C. Supernatants 
were removed, and pellets were washed before resuspending. Both super-
natants and pellets were analyzed by SDS-PAGE.
In competition experiments, KIND or NTSpir was added in a two-
fold concentration series ranging from 16 to 0.0625 μM (i.e., 16, 8, 4, 
...0.0625 μM), and 20 μg/ml BSA was added as a loading standard. 
These gels were stained with Sypro-Red (Invitrogen) and quantiﬁ  ed using 
a multiformat imager (Typhoon 9400; GE Healthcare) and ImageQuant 
software (GE Healthcare). We determined the dissociation constant of the 
unlabeled protein by ﬁ  tting binding data to the equation above. In this 
case, Kd2 is the dissociation constant of the competitor (KIND or NTSpir) 
for Capu-FH1FH2, [C] is the concentration of the competitor, and [Ro] is 
the concentration of free Capu-FH1FH2 when [C] = 0. For this analysis, 
Kd2 was determined by ﬂ  uorescence anisotropy (5 nM), and Kd, the dis-
sociation constant of Capu-FH1FH2 for microtubules, is determined by 
ﬁ  tting the above equation to experimental data. This function is an ap-
proximation and is only valid when the competitor and microtubules are 
in excess over Capu-FH1FH2. Only the data points that met these con-
ditions were ﬁ  t.
Cross-linking assays
Two actin-binding assays were used. An actin cross-linking assay was per-
formed according to Harris et al. (2006) with minor modiﬁ  cations. 50-μl solu-
tions containing 2 μM phalloidin-stabilized actin plus 0.5 μM Capu-FH1FH2 
or α-actinin or each component separately were mixed in KMEH, allowed 
to stand at RT for 10 min, and centrifuged at 16,000 g for 5 min. 40 μl of 
the supernatant was removed, and the pellet was washed once and resus-
pended in 50 μl. Equal amounts of supernatants and pellets were analyzed 
by SDS-PAGE. For microscopy experiments, we substituted AlexaFluor488-
phalloidin for unlabeled phalloidin. After standing for at least 10 min, solutions 
were diluted 1:100 in KMEH and added to poly-L-lysine–coated ﬂ  ow chambers 
at room temperature. Images were collected with a plan Apo 60× 1.2 NA 
objective lens and camera (C4742-98; Hamamatsu) on a microscope (TE300; 
Nikon) with Simple PCI software (Compix, Inc.).
Two microtubule cross-linking assays were used. The ﬁ  rst assay was 
performed according to the methods of Westermann et al. (2005). 50-μl 
solutions containing 10 μM tubulin (doped with 10% rhodamine-tubulin 
[Cytoskeleton, Inc.]) plus 0.5 μM Capu-FH1FH2 or GST-Spastin(E542A) 
(a mutant in the Walker B site that does not sever [Roll-Mecak and Vale, 
2005]) were mixed on ice in 80 mM Pipes, pH 6.9, 1 mM EGTA, 1 mM 
MgCl2, 1 mM GTP, and 25% glycerol. They were incubated at 37°C for 25 min 
and ﬁ  xed with 1% gluteraldehyde. Samples were diluted 1:100, introduced 
into a ﬂ  ow chamber, and examined by ﬂ  uorescence microscopy. For the 
second assay, the microtubules were prepolymerized at high concentration 
(18 μM), taxol stablized, and diluted and combined with Capu-FH1FH2 
or GST-Spastin(E542A) (10:0.5 μM). These solutions were allowed to 
stand at room temperature for at least 15 min before dilution (1:100) and 
visualization in a ﬂ  ow chamber, with the same equipment used for actin 
cross-linking assays.
Online supplemental material
Fig. S1 shows a stage 9 egg chamber expressing Spir-mRFP (A), immuno-
ﬂ  uorescence and Western blots showing the speciﬁ  city of anit-Spir antibody 
(B–D), complete Western blots from Fig. 1 E (E), and a Western blot of 
an oocyte coimmunoprecipitated with and without latrunculin (F). Fig. S2 
shows additional images of Spir and Capu expression in NIH 3T3 cells 
(A–D), GST pull-down with mammalian isoforms of Spir and Capu (E), an 
anisotropy experiment with Capu-FH2 (F), and an anisotropy experiment 
with mammalian isoforms of Spir and Capu (G). Fig. S3 shows the in-
hibition of Capu-FH2–mediated actin nucleation by KIND (A–C), sample 
analysis of polymerization assays (D), the inhibition curve for mammalian 
isoforms of Spir and Capu (E), and alternate inhibition analysis (F). Fig. S4 
shows that KIND does not inﬂ  uence spontaneous actin polymerization 
(A and B) and that Spir-1–KIND does not interact with mDia1 or mDia2 (C). 
Fig. S5 shows gels of FH2 domains and KIND mixed with tubulin (A and B), 
a cosedimentation assay with Capu-FH1FH2, tubulin, and NTSpir (instead 
of KIND; C and D), and images of Capu-FH1FH2–mediated tubulin 
polymerization and bundling of microtubules and actin (E–G). Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200706196/DC1.
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